YuYi peptideRetatrutide
Ordered Retatrutide from YuYi peptide? Mail in a sample (US only) and let us test it for free.
Test my supplyYuYi peptide's Retatrutide record is mixed: the first test failed identity with 0% purity/quantity, then Jan samples passed at 99.7–99.8% with near-label fill. No batch IDs or price/review corroboration make the sparse rebound uncertain.
GitHub repository metadata and an ECHEMI trading-platform listing conflict with YuYi's manufacturer-history narrative. The report traces the GitHub Pages, Gmail and WhatsApp sales stack, buyer-issued COA language, unresolved location signals and the missing payment-processor trail.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including YuYi peptide rows.
Cancel anytime
About YuYi peptide test results from Finnrick
YuYi peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 8 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible YuYi peptide peptides in this dataset are Retatrutide (4 tests), Tirzepatide (4 tests) and Wolverine (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 8 recent tests.
Ordered Retatrutide from YuYi peptide? Mail in a sample (US only) and let us test it for free.
Test my supply